Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 47.3% during mid-day trading on Monday . The stock traded as low as $0.63 and last traded at $0.63. Approximately 600 shares changed hands during trading, a decline of 86% from the average daily volume of 4,229 shares. The stock had previously closed at $1.20.
Ascletis Pharma Stock Performance
The business’s fifty day moving average price is $0.75 and its 200 day moving average price is $0.39.
About Ascletis Pharma
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Further Reading
- Five stocks we like better than Ascletis Pharma
- Investing in the High PE Growth Stocks
- Options Activity Points to More Volatility for Palantir Stock
- What is the S&P 500 and How It is Distinct from Other Indexes
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- The Basics of Support and Resistance
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
